Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm

Affiliations

¹ Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna 40138, Italy. Electronic address: giuseppe.lamberti8@unibo.it.
² Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna 40138, Italy.

Comment

Giuseppe Lamberti et al. Lancet Oncol. 2023 May.

. 2023 May;24(5):e187.

doi: 10.1016/S1470-2045(23)00059-1.

¹ Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna 40138, Italy. Electronic address: giuseppe.lamberti8@unibo.it.
² Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna 40138, Italy.

No abstract available

Conflict of interest statement

We declare no competing interests.

Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm - Authors' reply.
Kaderli RM, Nesti C, Bräutigam K, Zwahlen M, Perren A. Kaderli RM, et al. Lancet Oncol. 2023 May;24(5):e190-e191. doi: 10.1016/S1470-2045(23)00114-6. Lancet Oncol. 2023. PMID: 37142378 No abstract available.

Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.
Nesti C, Bräutigam K, Benavent M, Bernal L, Boharoon H, Botling J, Bouroumeau A, Brcic I, Brunner M, Cadiot G, Camara M, Christ E, Clerici T, Clift AK, Clouston H, Cobianchi L, Ćwikła JB, Daskalakis K, Frilling A, Garcia-Carbonero R, Grozinsky-Glasberg S, Hernando J, Hervieu V, Hofland J, Holmager P, Inzani F, Jann H, Jimenez-Fonseca P, Kaçmaz E, Kaemmerer D, Kaltsas G, Klimacek B, Knigge U, Kolasińska-Ćwikła A, Kolb W, Kos-Kudła B, Kunze CA, Landolfi S, La Rosa S, López CL, Lorenz K, Matter M, Mazal P, Mestre-Alagarda C, Del Burgo PM, van Dijkum EJMN, Oleinikov K, Orci LA, Panzuto F, Pavel M, Perrier M, Reims HM, Rindi G, Rinke A, Rinzivillo M, Sagaert X, Satiroglu I, Selberherr A, Siebenhüner AR, Tesselaar MET, Thalhammer MJ, Thiis-Evensen E, Toumpanakis C, Vandamme T, van den Berg JG, Vanoli A, van Velthuysen MF, Verslype C, Vorburger SA, Lugli A, Ramage J, Zwahlen M, Perren A, Kaderli RM. Nesti C, et al. Lancet Oncol. 2023 Feb;24(2):187-194. doi: 10.1016/S1470-2045(22)00750-1. Epub 2023 Jan 11. Lancet Oncol. 2023. PMID: 36640790